OrthoPediatrics insider sells 38,300 shares
Rhea-AI Filing Summary
ORTHOPEDIATRICS CORP (KIDS) received a Form 4 from director and ten percent owner David R. Pelizzon reporting sales of common stock held indirectly through Squadron Capital LLC. On 2026-08-24, 2026-08-25, and 2026-08-26, Squadron sold a total of 38,300 shares of Orthopediatrics common stock in open-market or private transactions at weighted average prices reported as $25.75, $24.74, and $24.28 per share, each with detailed price ranges provided in footnotes. A separate entry shows Pelizzon holding 44,384 shares directly as of 2026-08-24, including 17,959 restricted stock shares. Footnotes state the sales were undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses and that Pelizzon may be deemed a beneficial owner through his role at Squadron but expressly disclaims beneficial ownership except to the extent of his pecuniary interest.
Positive
- None.
Negative
- None.
Insights
Analyzing...
Insider Trade Summary
Net Seller: 38,300 shares
Net Sell
4 txns
Insider
Pelizzon David R
Role
Director, 10% Owner
Sold
38,300 shs ($943K)
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock F1, F5, F3 | 18,000 | $24.28 | $437K |
| Sale | Common Stock F1, F4, F3 | 16,300 | $24.74 | $403K |
| Sale | Common Stock F1, F2, F3 | 4,000 | $25.75 | $103K |
| holding | Common Stock F6 | -- | -- | -- |
Holdings After Transaction:
Common Stock — 6,863,464 shares (Indirect, See footnote);
Common Stock — 44,384 shares (Direct)
Footnotes (6)
- F1. This sale was undertaken by Squadron Capital LLC to provide additional capital for its other portfolio businesses.
- F2. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.50 to $25.82, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F3. These shares are held by Squadron Capital LLC ("Squadron"). As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these shares. The reporting person expressly disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein. The inclusion of these shares in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
- F4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.53 to $24.88, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- F5. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $24.13 to $24.36, inclusive. The reporting person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote
- F6. Includes restricted stock awards totaling 17,959 shares.
Key Figures
Total shares sold: 38,300 shares
Shares sold on 2026-08-24: 4,000 shares at $25.75 per share
Shares sold on 2026-08-25: 16,300 shares at $24.74 per share
+3 more
6 metrics
Total shares sold
38,300 shares
Aggregate of all reported sales of Orthopediatrics common stock in August 2026
Shares sold on 2026-08-24
4,000 shares at $25.75 per share
Weighted average price with detailed price range disclosed in a footnote
Shares sold on 2026-08-25
16,300 shares at $24.74 per share
Weighted average price with detailed price range disclosed in a footnote
Shares sold on 2026-08-26
18,000 shares at $24.28 per share
Weighted average price with detailed price range disclosed in a footnote
Direct holdings after transaction
44,384 shares
David R. Pelizzon’s directly held Orthopediatrics common stock as of 2026-08-24
Restricted stock awards included in direct holdings
17,959 shares
Restricted stock awards included within Pelizzon’s 44,384 directly held shares
Key Terms
weighted average price, beneficial owner, pecuniary interest, restricted stock awards
4 terms
weighted average price financial
"The price reported in Column 4 is a weighted average price."
Weighted average price is the average price of a security where each trade or component is counted according to its size, so bigger trades pull the average more than smaller ones. Think of it like calculating the average cost of a grocery haul where items you bought more of have greater influence on the final per-item cost. Investors use it to understand the true average price paid or received, judge execution quality, and compare trading performance against market movement.
beneficial owner financial
"the reporting person may be deemed to be the beneficial owner of these shares."
A beneficial owner is the person who ultimately owns or controls a financial asset or property, even if their name isn't directly on official documents. Think of it like someone who secretly holds the keys to a safe deposit box—others may appear to have access, but the true owner is the one who benefits from what's inside. Identifying beneficial owners helps ensure transparency and prevent illegal activities like money laundering or fraud.
pecuniary interest financial
"disclaims beneficial ownership of these shares, except to the extent of his pecuniary interest therein."
restricted stock awards financial
"Includes restricted stock awards totaling 17,959 shares."
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
FAQ
What insider transaction did KIDS report for David R. Pelizzon on this Form 4?
The filing reports that an entity associated with David R. Pelizzon, Squadron Capital LLC, sold a total of 38,300 shares of Orthopediatrics Corp common stock over three days in August 2026 in open-market or private transactions.
AI-generated analysis. How Rhea-AI works. Not financial advice.
